Submit your abstract now! Share your latest findings with the European community and be considered for an oral or poster presentation during EEC 2024, and be considered for publication in Epilepsia.
Deadline for submission 2 February 2024
Abstract Submission Rules
- Abstracts will not be accepted unless they are submitted online via the online abstract submission system before midnight (GMT) on the deadline date. Abstracts received after this date will NOT be accepted. Abstracts submitted by post, fax or email will NOT be considered.
- All abstracts should be written, submitted and presented in English with a maximum word count of 300 words (not including the abstract title, authors and institutions).
- Authors will be notified in writing as to whether or not their abstract has been accepted by the Abstract Review Committee. The decision of the committee is final and no correspondence will be entered into.
- Once an abstract has been accepted, the presenting author must register for the congress for final acceptance. An abstract presenter may not register as a day delegate.
- Abstracts accepted and presented at the congress will be listed on the congress website. Subject to editorial review, abstracts may be published in a supplement to Epilepsia.
- The abstracts of authors who do not register for the congress will be excluded from publication.
- Instructions for both platform and e-poster presentations will be available on the congress website. Authors selected for oral presentations should use Microsoft PowerPoint only (PC format).
- All correspondence will be sent to the submitting author only. It is the responsibility of the submitting author to forward any relevant correspondence to the presenting author.
Abstract Content Rules
- Abstract submitters should ensure that the final version is submitted by the deadline; changes will not be permitted once the deadline has passed.
- Institution information should be provided for all authors. Please include institution, city, state/ province and country but exclude department, division, laboratory, etc.
- A topic category for each abstract must be selected during the submission process.
- Abstracts should be structured in 4 sections as follows:
- Purpose: Should indicate the objectives of the work being presented.
- Method: Should describe study material or subjects (e.g. number and type of patients), intervention and evaluation procedures.
- Results: Should summarize the main findings. Wherever possible, give numerical values, including means with SD or SEM, and statistical significance or confidence intervals.
- Conclusion: Should state briefly the conclusions reached in the work.
- Figures, tables and other illustrations may not be included.
- If the work was supported by funds provided by a commercial organisation this should be stated in a short acknowledgment at the end of the abstract. Other sources of funding may be acknowledged in the same way.
- Submission of multiple abstracts describing different components of the same study is not appropriate. All findings generated from the same study should be included in a single abstract.
- Abstracts containing single case reports will not usually be accepted, unless the report is of outstanding scientific or clinical interest because of the uniqueness of the findings or the sophistication of the investigations.
- Abstracts containing data considered to be insufficiently informative will not be accepted.
- Authors should use a concise title that indicates the content of the abstract. Abbreviations should be avoided in the title.
- For intervention studies (for example, therapeutic trials), type of design (prospective or retrospective, controlled or uncontrolled, randomized or observational, open vs. single-blind vs. double-blind), dosages, assessment methods and duration of follow-up should be specified.
- Non-proprietary names of drugs must be used throughout. If results are considered to be specific for a given proprietary product (for example, bio-equivalence studies), the non-proprietary name must still be used, followed by the proprietary name and the name of the manufacturers in brackets.
- Abbreviations should be used sparingly. For words that are abbreviated, use the whole term the first time, followed by the standard abbreviation in parenthesis.
- References should be used sparingly. They should be included within the text in brackets. For journals, mention first author “et al”, followed by the name of the journal as abbreviated in the Index Medicus, year, volume number and inclusive pages (e.g. Hardus P et al. Epilepsia 2001;42:262-267.). For book chapters, give first author “et al”, editor, title, publisher, city of publication, year and inclusive pages (e.g. Levy RH et al. In: Levy RH et al, Antiepileptic Drugs. Lippincott-Raven, 1996;13-30.).
- Submission of an abstract automatically implies acknowledgment that the work described was conducted in accordance with current ethical standards and regulations in biomedical research. Failure to adhere to these standards will result in rejection of the abstract.
How do I submit an abstract?
Abstracts will only be accepted for review if submitted via the congress abstract submission system which will open shortly.
Can I make changes to my abstract after submission?
You may make changes to your submitted abstract until the official submission deadline.
Once the abstract submission deadline has passed, changes are not permitted unless they relate to the results of the study. In this case only, please contact firstname.lastname@example.org.
Can I submit an abstract after the deadline?
Abstracts will not be accepted for review after the deadline. Please contact email@example.com with any queries.
Can an Encore Abstract be submitted?
Yes an encore abstract may be submitted, provided that there is no copyright issue with the original publisher.
What is the abstract word count?
Maximum word count is 300.
When will I know if my abstract has been accepted?
Authors will be notified of the outcome of the abstract review once completed.
How will I receive the information from the Secretariat?
Contact details provided at the time of submission will be used for all correspondence related to the congress. Please ensure that the correct details are entered.
All correspondence will be sent to the submitting author only. It is the responsibility of the submitting author to forward any relevant correspondence to the presenting author, if different, and any co-authors.
How will my abstract be presented at the congress?
Authors of abstracts which have been accepted for presentation will receive all details by email using the contact details provided at the time of submission.
My colleague has received confirmation of their abstract acceptance and I did not, is there something wrong?
Please contact firstname.lastname@example.org.
Will my accepted abstract be published?
Abstracts accepted for presentation at the IEC will be considered for publication in Epilepsia. Those judged suitable by the editorial team based on novelty and scientific impact will be published electronically. Others may be accepted for presentation at the meeting but will not be published.
ABSTRACTS - GENERAL QUERIES
Which reference number should I use when I send a query to the Secretariat?
The personal ID Reference Number that you received when you submitted your abstract should be mentioned in all correspondence.
I am not the first author; may I present the poster on behalf of my colleagues?
Presentation by a second author may be allowed. Once your registration has been completed, please contact email@example.com. Please note however that each author is permitted to present only once during the congress (not including invited lectures).
Can the presenting author pay one-day registration fee (for the day when the poster is displayed)?
No. Once an abstract has been approved, the presenting author must register for the entire congress for final acceptance. An abstract presenter may not register as a day delegate. Non-registered authors may be excluded from publication.
I am an invited speaker in the congress programme; do I need to submit an abstract?
Invited speakers are not required to submit abstracts to illustrate their talks.
I have been selected for a platform session but I would have preferred a poster presentation, what can I do?
During the abstract submission process you were asked if you would prefer poster or oral (platform) presentation, or if you do not have a preference.
The Abstract Review Committee (ARC) took this preference into account and did not select an abstract for platform presentation if the submitter indicated that s/he does not want a platform presentation.
However, if you indicated that you had no preference between poster and platform presentation, then the ARC has selected your work to be presented in a platform session because they felt that it was of high quality and that a large audience would be interested in knowing more about the study. It would be a shame not to use this opportunity to present your work! However if you are unable to make an oral presentation please contact the secretariat at firstname.lastname@example.org for alternative arrangements.
How do I find information about e-posters?
All information relating to e-posters will be available on the website after the abstract review is completed.
- Adult Epileptology
- Basic science
- Clinical Neurophysiology
- Epilepsy and Comorbidities
- Drug Therapy
- Epilepsy and Reproductive Health
- Epilepsy in Older People
- Epilepsy in Resource-restricted Settings
- Epilepsy Surgery
- Paediatric Epileptology
- Social Issues/Nursing
- Status Epilepticus
- Terminology and Classification
- Epilepsy Infection and Inflammation
The ILAE Mentor-Mentee Programme involves the allocation of a mentor to a trainee.
Applications for the Mentor-Mentee Programme are only available through the congress abstract submission system. Applicants must submit an abstract to the congress in order to be eligible to apply for the programme.
If selected, the trainee will be allocated a mentor - an experienced individual in the research/clinical area in which the trainee demonstrates an interest. They will have the opportunity to meet with their mentor, as well as to listen to other individuals established in their careers in different regions of the world. The mentor will arrange to attend the trainee’s presentation/poster and offer further consultation.
Participants in the ILAE Mentor-Mentee Programme do not receive any support to attend the congress.
*Please note that applicants must submit an abstract to the congress in order to be eligible to apply for the programme.
Please contact the ILAE Secretariat at email@example.com with any queries.
CRITERIA & SELECTION
- Applications for the ILAE Mentor-Mentee Programme will only be accepted via the online abstract submission system for the congress.
- At the time of application, the applicant must be aged 40 years of age or under. A copy of the applicant’s passport/ID document must be included with the application to verify date of birth.
- At time of application, the applicant must be a trainee:
for MDs: within 2 years of start of fellowship
for non-MDs: being enrolled in a graduate student programme (Masters or PhD)
- The applicant must submit a signed letter from a supervisor indicating the applicant fulfils the criteria, including that the work in the abstract submitted is mostly the work of the applicant.
In order to encourage young researchers to participate in the congress, bursaries will be awarded to a number of applicants who have submitted an abstract to the congress that stands out for its scientific quality.
Bursary awards assist awardees with costs in order to attend the congress.
Applications for bursaries will only be accepted from those who also submit an abstract and application is made via the abstract submission system.
Please contact the ILAE Secretariat at firstname.lastname@example.org with any queries.
REQUIREMENTS AND CONDITIONS
- Applications for bursaries will only be accepted via the online abstract submission system for the congress.
- The applicant must submit an abstract and receive a score higher than 3.5 out of 5.
- At the time of application, the applicant must be 45 years of age or under. A copy of the applicant’s passport/ID document must be included with the application to verify date of birth.
- The applicant must submit a short statement explaining why attendance at the congress would be particularly relevant to his/her present appointment or activity in the field of epilepsy, making sure to indicate the reason he/she requires funding to attend the congress and why he/she feels the application should be considered.
- The applicant must submit a signed reference from a person supporting his/her application (e.g. local ILAE Chapter representative, Head of Department of hospital or institution, etc.).
- The applicant must declare if he/she has sourced any other funding to attend the congress and disclose the nature of the funding.
Congress Begins7 September, 2024
Abstract Submission Closes2 February, 2024
EEC Forum Submission Closes1 December, 2023
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community